Up next

Autoplay

Minimum Residual Disease in Acute Lymphoblastic Leukemia

5 Views • 08/04/23
Share
Embed
administrator
administrator
Subscribers
0

In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay